Cargando…
Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
Coronavirus disease 2019 patients admitted to the ICU have high mortality. The host response to coronavirus disease 2019 has only been partially elucidated, and prognostic biomarkers have not been identified. We performed targeted proteomics on critically ill coronavirus disease 2019 patients to bet...
Autores principales: | Fraser, Douglas D., Cepinskas, Gediminas, Patterson, Eric K., Slessarev, Marat, Martin, Claudio, Daley, Mark, Patel, Maitray A., Miller, Michael R., O’Gorman, David B., Gill, Sean E., Pare, Guillaume, Prassas, Ioannis, Diamandis, Eleftherios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449255/ https://www.ncbi.nlm.nih.gov/pubmed/32904064 http://dx.doi.org/10.1097/CCE.0000000000000189 |
Ejemplares similares
-
Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021) -
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Novel plasma protein biomarkers from critically ill sepsis patients
por: Van Nynatten, Logan R., et al.
Publicado: (2022)